SCHEMBL6586743

SCHEMBL6586743

CN(C)C(=O)C(C1CCNCC1)N1CCC(N)CC1

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CPN1 P15169 1/20 0.32
CPB2 Q96IY4 1/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
DPP4 P27487 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6584546 0.86 SLC6A2 (0.35) CPN1CPB2SLC6A2SLC6A4SLC6A3
SCHEMBL7839828 0.84 OPRD1 (0.38) CPN1CPB2SLC6A2SLC6A4SLC6A3
SCHEMBL6584321 0.84
SCHEMBL6585188 0.83 CPN1 (0.34) CPN1CPB2SLC6A2SLC6A4SLC6A3
SCHEMBL6586012 0.81 SMYD3 (0.32) CPN1CPB2SLC6A2SLC6A4SLC6A3
SCHEMBL6585899 0.81 SLC6A3 (0.43) CPN1CPB2SLC6A2SLC6A4SLC6A3
SCHEMBL6584313 0.78 DPP4 (0.37) CPN1CPB2DPP4
SCHEMBL6586715 0.77 CA2 (0.38) DPP4
SCHEMBL6586597 0.76 CTSK (0.44)
SCHEMBL6587799 0.75 SLC6A2 (0.31) CPN1CPB2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1076055-B1 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS DAINIPPON PHARMACEUTICAL CO (JP) 2004-11-24 EP disclosed
US-6294555-B1 SEROTONIN HT3 RECEPTOR ANTAGONIST FOR GASTROINTESTINAL DISORDERS DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2001-09-25 US disclosed
EP-1076055-A1 1- (1-SUBSTITUTED-4-PIPERIDINYL)METHYL]-4-PIPERIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, MEDICINAL COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES OF THESE COMPOUNDS Dainippon Pharmaceutical Co., Ltd. (JP) 2001-02-14 EP disclosed